Structures by: Nangia A.
Total: 676
Naftopidil_Benzoic acid_Salt
C31H34N2O5
IUCrJ (2018) 5, 6
a=11.0695(2)Å b=17.7360(3)Å c=13.5179(3)Å
α=90° β=97.3794(19)° γ=90°
Naftopidil_2, 6-Dihydroxybenzoic acid_Salt
C31H34N2O7
IUCrJ (2018) 5, 6
a=11.4733(3)Å b=17.6286(5)Å c=13.6530(4)Å
α=90° β=93.290(2)° γ=90°
Naftopidil_2-Hydroxybenzoic acid_Salt
C31H34N2O6
IUCrJ (2018) 5, 6
a=11.2350(5)Å b=17.6516(6)Å c=13.4798(6)Å
α=90° β=96.269(4)° γ=90°
Naftopidil_2, 3-Dihydroxybenzoic acid_Salt
C31H34N2O7
IUCrJ (2018) 5, 6
a=11.3258(4)Å b=17.8349(7)Å c=13.4077(7)Å
α=90° β=95.800(4)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_Salt alloy
C31H34N2O5.9
IUCrJ (2018) 5, 6
a=11.197(2)Å b=17.627(4)Å c=13.199(3)Å
α=90° β=96.347(6)° γ=90°
Naftopidil_Benzoic acid_2, 3-Dihydroxybenzoic acid_Salt alloy
C31H34.42N2O6.42
IUCrJ (2018) 5, 6
a=11.282(4)Å b=17.856(7)Å c=13.460(5)Å
α=90° β=96.060(12)° γ=90°
Naftopidil_2, 4-Dihydroxybenzoic acid_Salt
C31H34N2O7
IUCrJ (2018) 5, 6
a=10.843(4)Å b=17.862(6)Å c=13.913(6)Å
α=90° β=91.715(12)° γ=90°
Naftopidil_2-Hydroxybenzoic acid_2, 3-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.51
IUCrJ (2018) 5, 6
a=11.253(4)Å b=17.660(6)Å c=13.247(4)Å
α=90° β=95.787(11)° γ=90°
Naftopidil_2-Hydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_Salt alloy
C31H34.55N2O6.14
IUCrJ (2018) 5, 6
a=11.176(4)Å b=17.608(5)Å c=13.305(4)Å
α=90° β=95.426(10)° γ=90°
Naftopidil_Benzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C62H67.84N4O11.72
IUCrJ (2018) 5, 6
a=11.346(2)Å b=17.508(4)Å c=13.400(3)Å
α=90° β=98.15(3)° γ=90°
Naftopidil_2-Hydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.47
IUCrJ (2018) 5, 6
a=11.487(7)Å b=17.514(10)Å c=13.310(9)Å
α=90° β=95.95(3)° γ=90°
Naftopidil_2, 3-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H33N2O7
IUCrJ (2018) 5, 6
a=11.475(6)Å b=17.669(9)Å c=13.248(7)Å
α=90° β=94.87(2)° γ=90°
Naftopidil_2, 3-Dihydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_Salt alloy
C31H34N2O7
IUCrJ (2018) 5, 6
a=11.195(15)Å b=17.69(3)Å c=13.449(18)Å
α=90° β=94.40(5)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid _2, 3-Dihydroxybenzoic acid_Salt alloy
C31H34.12N2O6.33
IUCrJ (2018) 5, 6
a=11.296(2)Å b=17.807(4)Å c=13.459(3)Å
α=90.00(3)° β=95.99(3)° γ=90.00(3)°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.17
IUCrJ (2018) 5, 6
a=11.199(20)Å b=17.71(3)Å c=13.40(3)Å
α=90° β=94.85(7)° γ=90°
Naftopidil_Benzoic acid_2, 3-Dihydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.46
IUCrJ (2018) 5, 6
a=11.102(5)Å b=17.701(9)Å c=13.437(6)Å
α=90° β=94.667(18)° γ=90°
Naftopidil_Benzoic acid_2, 3-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.4
IUCrJ (2018) 5, 6
a=11.410(4)Å b=17.772(6)Å c=13.550(5)Å
α=90° β=95.891(19)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.27
IUCrJ (2018) 5, 6
a=11.369(4)Å b=17.660(6)Å c=13.539(5)Å
α=90° β=95.632(17)° γ=90°
Naftopidil_2, 3-Dihydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O7
IUCrJ (2018) 5, 6
a=11.319(2)Å b=17.672(4)Å c=13.391(3)Å
α=90.00(3)° β=93.90(3)° γ=90.00(3)°
Naftopidil_2-Hydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_2, 6-dihydroxybenzoic acid_Salt alloy
C62H68.91N4O13.03
IUCrJ (2018) 5, 6
a=11.246(10)Å b=17.607(16)Å c=13.523(13)Å
α=90° β=94.19(4)° γ=90°
Naftopidil_2-Hydroxybenzoic acid_2, 3-Dihydroxybenzoic acid_2, 6-dihydroxybenzoic acid_Salt alloy
C31H34N2O6.81
IUCrJ (2018) 5, 6
a=11.405Å b=17.746Å c=13.511Å
α=90° β=95.49° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 3-Dihydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_Salt alloy
C31.1H33.33N2O6.35
IUCrJ (2018) 5, 6
a=11.153(4)Å b=17.701(5)Å c=13.336(4)Å
α=90° β=95.232(17)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 3-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.69
IUCrJ (2018) 5, 6
a=11.404(5)Å b=17.591(8)Å c=13.269(6)Å
α=90° β=95.526(15)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C62H67.8N4O12.63
IUCrJ (2018) 5, 6
a=11.237(5)Å b=17.571(6)Å c=13.374(6)Å
α=90° β=94.584(16)° γ=90°
Naftopidil_Benzoic acid_2-Hydroxybenzoic acid_2, 3-Dihydroxybenzoic acid_2, 4-Dihydroxybenzoic acid_2, 6-Dihydroxybenzoic acid_Salt alloy
C31H34N2O6.49
IUCrJ (2018) 5, 6
a=11.279(5)Å b=17.633(7)Å c=13.377(6)Å
α=90° β=94.51(2)° γ=90°
Naftopidil_2,4,6-trihydroxybenzoic acid salt
C24H29N2O3,C7H5O5
IUCrJ (2018) 5, 6
a=11.074(2)Å b=17.895(3)Å c=14.000(2)Å
α=90° β=92.859(8)° γ=90°
CEL2HP
C17H14F3N3O2S,C5H5NO
IUCrJ (2019) 6, 4
a=14.5182(15)Å b=8.2844(12)Å c=17.8349(18)Å
α=90° β=93.899(9)° γ=90°
CELMeHP
C17H14F3N3O2S,C6H7NO
IUCrJ (2019) 6, 4
a=10.0694(8)Å b=10.6113(10)Å c=12.6499(14)Å
α=113.451(10)° β=100.897(8)° γ=101.744(7)°
CELMeTFHP
C17H14F3N3O2S,C7H6F3NO
IUCrJ (2019) 6, 4
a=7.4563(9)Å b=13.0100(15)Å c=13.7231(16)Å
α=100.170(2)° β=95.715(2)° γ=104.444(2)°
CELOMeHP
C6H7NO2,C17H14F3N3O2S
IUCrJ (2019) 6, 4
a=7.6112(9)Å b=11.3462(14)Å c=15.1063(18)Å
α=105.897(2)° β=102.702(2)° γ=101.930(2)°
FUROS2PY
2(C12H11ClN2O5S),C2H7O,2(C4H7NO)
IUCrJ (2019) 6, 4
a=23.819(3)Å b=8.4372(5)Å c=23.450(2)Å
α=90° β=123.868(16)° γ=90°
FUROSCPR
C12H11ClN2O5S,C6H11NO
IUCrJ (2019) 6, 4
a=8.5442(6)Å b=11.3615(8)Å c=12.1409(8)Å
α=63.4470(10)° β=88.7240(10)° γ=75.7120(10)°
FUROSVLM
C12H11ClN2O5S,C5H9NO,H2O
IUCrJ (2019) 6, 4
a=11.116(5)Å b=8.447(2)Å c=21.388(7)Å
α=90° β=93.12(3)° γ=90°
HCT2HPFORMI
C7H8ClN3O4S2,C5H5NO
IUCrJ (2019) 6, 4
a=6.8039(5)Å b=13.5399(8)Å c=18.8949(13)Å
α=90° β=113.113(9)° γ=90°
HCTHPFORMII
C7H8ClN3O4S2,C5H5NO
IUCrJ (2019) 6, 4
a=29.442(4)Å b=7.3421(9)Å c=7.0867(7)Å
α=90° β=90° γ=90°
HCTVLM12
C7H8ClN3O4S2,2(C5H9NO)
IUCrJ (2019) 6, 4
a=8.6930(6)Å b=10.6472(7)Å c=12.8556(9)Å
α=113.6720(10)° β=98.9000(10)° γ=95.3580(10)°
HCTCPR12
C7H8ClN3O4S2,2(C6H11NO)
IUCrJ (2019) 6, 4
a=11.8873(12)Å b=19.315(2)Å c=21.733(2)Å
α=90° β=90° γ=90°
C16H16ClN5O6S
C16H16ClN5O6S
Journal of Pharmaceutical Sciences (2012) 101, 664-680
a=7.909(4)Å b=9.467(5)Å c=12.484(7)Å
α=100.151(8)° β=95.950(8)° γ=97.644(9)°
C20H18ClN6O7S
C20H18ClN6O7S
Journal of Pharmaceutical Sciences (2012) 101, 664-680
a=7.512(2)Å b=9.462(3)Å c=17.198(5)Å
α=95.387(5)° β=102.271(5)° γ=110.101(5)°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.0683(4)Å b=10.7464(6)Å c=15.6155(8)Å
α=90° β=90.890(2)° γ=90°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=15.441(3)Å b=8.3179(16)Å c=10.6014(18)Å
α=90° β=90° γ=90°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.6916(6)Å b=10.2641(7)Å c=15.4965(10)Å
α=90° β=90.186(2)° γ=90°
(E)-N'-(3,5-dibromo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Br2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.266(2)Å b=10.917(2)Å c=15.734(3)Å
α=90.00(3)° β=95.82(3)° γ=90.00(3)°
(E)-N'-(3,5-dibromo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Br2N3O2
IUCrJ (2017) 4, 6 812-823
a=9.8084(7)Å b=10.7751(8)Å c=13.9516(9)Å
α=103.219(3)° β=94.907(3)° γ=91.018(3)°
(E)-N'-(3-bromo-5-chloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9BrClN3O2
IUCrJ (2017) 4, 6 812-823
a=8.2475(9)Å b=10.8035(11)Å c=15.7971(15)Å
α=90° β=96.098(3)° γ=90°
(E)-N'-(3-bromo-5-chloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9BrClN3O2
IUCrJ (2017) 4, 6 812-823
a=8.651(2)Å b=10.446(3)Å c=15.680(4)Å
α=90° β=94.116(11)° γ=90°
(E)-N'-(3,5-diiodo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9I2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.2946(5)Å b=11.2673(6)Å c=16.2177(10)Å
α=90° β=97.993(2)° γ=90°
(E)-N'-(3,5-difluoro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9F2N3O2
IUCrJ (2017) 4, 6 812-823
a=7.897(2)Å b=10.396(2)Å c=14.989(3)Å
α=90.00(3)° β=92.27(3)° γ=90.00(3)°
ACEMETACIN2PYRIDONE
C21H18ClNO6,C5H5NO
IUCrJ (2017) 4, 3
a=23.1400(18)Å b=5.1900(8)Å c=21.2642(19)Å
α=90.00° β=111.714(17)° γ=90.00°
ACEMETACINNICOTINAMIDEFORMII
C21H18ClNO6,C6H6N2O,H2O
IUCrJ (2017) 4, 3
a=21.348(2)Å b=4.1931(12)Å c=15.2174(19)Å
α=90.567(17)° β=101.40(2)° γ=89.473(16)°
ACEMETACINNICOTINAMIDEFORMI
C21H18ClNO6,C6H6N2O
IUCrJ (2017) 4, 3
a=4.8977(11)Å b=40.914(4)Å c=12.8874(19)Å
α=90.00° β=100.328(18)° γ=90.00°
ACEMETACINPABA
C21H18ClNO6,C7H7NO2
IUCrJ (2017) 4, 3
a=17.2939(18)Å b=4.8191(7)Å c=16.9544(15)Å
α=90.00° β=113.529(17)° γ=90.00°
ACEMETACINVLM
C21H18ClNO6,C5H9NO
IUCrJ (2017) 4, 3
a=11.7638(12)Å b=20.5548(19)Å c=5.1627(9)Å
α=89.543(14)° β=93.300(16)° γ=96.276(17)°
C21H18ClNO6,C7H7NO2
C21H18ClNO6,C7H7NO2
IUCrJ (2014) 1, 2 136-150
a=16.959(6)Å b=4.7993(15)Å c=17.285(5)Å
α=90.00° β=113.55(4)° γ=90.00°
ACM-INA
C21H18ClNO6,C6H6N2O
IUCrJ (2014) 1, 2 136-150
a=11.8900(8)Å b=4.9621(3)Å c=21.4281(14)Å
α=90.00° β=90.663(6)° γ=90.00°
ACM-CPR
C21H18ClNO6,C6H11NO
IUCrJ (2014) 1, 2 136-150
a=11.9406(16)Å b=21.3081(19)Å c=5.1030(14)Å
α=92.373(15)° β=93.003(16)° γ=85.308(17)°
C6H8N2O2S,C6H11NO
C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.2731(4)Å b=15.9052(10)Å c=12.7766(6)Å
α=90.00° β=99.291(5)° γ=90.00°
C6H7NO2S,C7H13NO
C6H7NO2S,C7H13NO
IUCrJ (2015) 2, 4 389-401
a=7.3020(9)Å b=17.189(2)Å c=12.2835(16)Å
α=90.00° β=106.760(2)° γ=90.00°
C6H6ClNO2S,C6H11NO
C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.1564(13)Å b=13.369(2)Å c=15.276(3)Å
α=90.00° β=90.00° γ=90.00°
C6H8N2O2S,C6H11NO
C6H8N2O2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0957(6)Å b=13.1280(13)Å c=15.3425(18)Å
α=90.00° β=90.00° γ=90.00°
C6H6BrNO2S,C6H11NO
C6H6BrNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.156(3)Å b=13.538(5)Å c=15.406(6)Å
α=90.00° β=90.00° γ=90.00°
C6H6ClNO2S,C6H11NO
C6H6ClNO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=9.8782(6)Å b=14.1720(6)Å c=10.8753(6)Å
α=90.00° β=112.850(7)° γ=90.00°
C7H9NO2S,C5H9NO
C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.3367(6)Å b=15.9206(17)Å c=16.070(3)Å
α=90.00° β=98.308(12)° γ=90.00°
C6H7NO2S,C6H11NO
C6H7NO2S,C6H11NO
IUCrJ (2015) 2, 4 389-401
a=7.0700(9)Å b=12.7624(13)Å c=14.977(2)Å
α=90.00° β=90.00° γ=90.00°
C6H6BrNO2S,C5H9NO
C6H6BrNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=25.914(3)Å b=6.8687(9)Å c=19.202(2)Å
α=90.00° β=126.873(2)° γ=90.00°
C7H9NO2S,C5H9NO
C7H9NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=5.210(3)Å b=8.449(4)Å c=16.104(8)Å
α=82.894(8)° β=82.798(8)° γ=81.772(8)°
C6H6ClNO2S,C5H9NO
C6H6ClNO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=10.521(2)Å b=13.7661(12)Å c=10.3407(16)Å
α=90.00° β=116.31(2)° γ=90.00°
C6H7NO2S,C5H9NO
C6H7NO2S,C5H9NO
IUCrJ (2015) 2, 4 389-401
a=7.1043(5)Å b=12.7937(10)Å c=14.0302(16)Å
α=90.00° β=90.00° γ=90.00°
((E)-4-((3,5-Dichloro-2-Hydroxybenzylidene)amino)benzamide
C14H10Cl2N2O2
IUCrJ (2017) 4, 3
a=8.4492(7)Å b=9.1167(5)Å c=9.1545(8)Å
α=81.461(6)° β=77.033(7)° γ=80.551(6)°
((E)-4-((3,5-Dichloro-2-Hydroxybenzylidene)amino)benzamide
C14H10Cl2N2O2
IUCrJ (2017) 4, 3
a=8.3558(4)Å b=12.7516(9)Å c=13.0135(9)Å
α=78.050(6)° β=77.167(5)° γ=88.734(4)°
((E)-4-((3,5-Dichloro-2-Hydroxybenzylidene)amino)benzamide
C14H10Cl2N2O2
IUCrJ (2017) 4, 3
a=7.2798(9)Å b=13.2794(15)Å c=14.5473(9)Å
α=87.618(7)° β=80.816(7)° γ=75.707(10)°
((E)-4-((3,5-Dibromo-2-Hydroxybenzylidene)amino)benzamide
C14H10Br2N2O2
IUCrJ (2017) 4, 3
a=8.3928(7)Å b=9.2815(8)Å c=9.3877(8)Å
α=81.620(7)° β=75.049(7)° γ=81.589(7)°
((E)-4-((3,5-Dichloro-2-Hydroxybenzylidene)amino)benzamide
C14H10Cl2N2O2
IUCrJ (2017) 4, 3
a=7.4309(14)Å b=13.296(2)Å c=14.694(3)Å
α=87.600(6)° β=80.034(7)° γ=75.859(7)°
((E)-4-((3,5-Diiodo-2-Hydroxybenzylidene)amino)benzamide
C14H10I2N2O2
IUCrJ (2017) 4, 3
a=8.4678(6)Å b=9.6066(7)Å c=9.6522(7)Å
α=81.239(2)° β=84.450(2)° γ=72.336(2)°
ACETAZOLAMIDE;DMSO
C4H6N4O3S2,0.5(C2H6OS)
IUCrJ (2016) 3, 2 152-160
a=52.62(3)Å b=4.816(2)Å c=17.814(9)Å
α=90.00° β=106.785(13)° γ=90.00°
ACETAZOLAMIDE;2 PYRIDONE
C4H6N4O3S2,C5H5NO
IUCrJ (2016) 3, 2 152-160
a=4.9138(4)Å b=33.192(3)Å c=8.3659(7)Å
α=90.00° β=99.5200(10)° γ=90.00°
ACETAZOLAMIDE;2 PYRIDONE
C4H6N4O3S2,2(C5H5NO)
IUCrJ (2016) 3, 2 152-160
a=6.8501(3)Å b=11.3563(6)Å c=12.3387(8)Å
α=82.288(5)° β=81.856(4)° γ=75.804(4)°
ACETAZOLAMIDE; CAPROLACTAM; HYDRATE
C4H6N4O3S2,C6H11NO,H2O
IUCrJ (2016) 3, 2 152-160
a=4.9969(2)Å b=11.6983(6)Å c=14.6244(8)Å
α=70.868(5)° β=81.892(4)° γ=80.262(4)°
ACETAZOLAMIDE;NICOTINAMIDE
C4H6N4O3S2,C6H6N2O
IUCrJ (2016) 3, 2 152-160
a=5.1477(8)Å b=10.8147(14)Å c=14.2604(16)Å
α=69.797(11)° β=85.463(12)° γ=81.889(12)°
ACETAZOLAMIDE;6 Me 2 PYRIDONE
C4H6N4O3S2,C6H7NO
IUCrJ (2016) 3, 2 152-160
a=11.3972(7)Å b=18.1641(3)Å c=10.338(3)Å
α=90.00° β=97.046(16)° γ=90.00°
ACETAZOLAMIDE; 3 OME 2 PYRIDONE
C4H6N4O3S2,C6H7NO2,H2O
IUCrJ (2016) 3, 2 152-160
a=7.7872(6)Å b=10.2130(7)Å c=10.2464(7)Å
α=88.192(5)° β=76.587(6)° γ=77.996(6)°
ACETAZOLAMIDE;NICOTINAMIDE; 2 PYRIDONE
C4H6N4O3S2,C6H6N2O,C5H5NO
IUCrJ (2016) 3, 2 152-160
a=7.0347(3)Å b=10.2539(7)Å c=13.7934(9)Å
α=81.685(6)° β=83.028(5)° γ=88.283(5)°
ACETAZOLAMIDE; VALEROLACTAM
C4H6N4O3S2,2(C5H9NO)
IUCrJ (2016) 3, 2 152-160
a=9.66166(19)Å b=23.4685(4)Å c=8.84352(17)Å
α=90.00° β=100.7730(19)° γ=90.00°
2,3,5-Pyrazine tricarboxylic acid dihydrate
C7H4N2O6.2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.2830(3)Å b=6.6497(3)Å c=13.8423(7)Å
α=93.064(2)° β=90.513(2)° γ=103.009(2)°
2,3,5,6-pyrazinetetracarboxylic acid dihydrate
C8H4N2O8.2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4385(10)Å b=6.3885(10)Å c=8.6809(10)Å
α=98.381(5)° β=107.406(5)° γ=105.573(5)°
2,3,5,6-pyrazinetetracarboxylic acid dihydrate
C8H4N2O8,2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4361(10)Å b=6.3699(10)Å c=8.6672(10)Å
α=97.911(5)° β=107.546(5)° γ=105.718(5)°
2,3,5,6-pyrazinetetracarboxylic acid dihydrate
C8H4N2O8,2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4606(10)Å b=6.4133(10)Å c=8.7164(10)Å
α=98.962(5)° β=107.408(5)° γ=105.348(5)°
2,3,5,6-pyrazinetetracarboxylic acid dihydrate
C8H4N2O8,2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.4950(10)Å b=6.4410(10)Å c=8.7670(10)Å
α=99.393(6)° β=107.565(7)° γ=105.174(7)°
2,3-Pyrazine dicarboxylic acid dihydrate
C6H4N2O4.2H2O
The Journal of Physical Chemistry A (2004) 108, 43 9406
a=5.3470(2)Å b=13.0286(4)Å c=11.7443(4)Å
α=90.00° β=99.0360(10)° γ=90.00°
3,3'-Bipyrrole ester
C28H28N2O4
Organic letters (2008) 10, 7 1373-1376
a=9.465(8)Å b=12.243(10)Å c=12.556(10)Å
α=116.306(13)° β=91.069(15)° γ=104.607(14)°
1:1 complex of barbituric acid and quinoxaline-N,N'-oxide
C8H6N2O2,C4H4N2O3
Molecular Pharmaceutics (2007) 4, 3 417
a=10.3850(9)Å b=7.2222(6)Å c=16.3763(14)Å
α=90.00° β=93.6860(10)° γ=90.00°
1:2 Cocrystal of Barbituric acid and 4-methylpyridine N-oxide
2(C6H7NO),C4H4N2O3
Molecular Pharmaceutics (2007) 4, 3 417
a=8.4083(7)Å b=9.8893(9)Å c=10.6761(9)Å
α=73.2010(10)° β=79.022(2)° γ=74.182(2)°
2:1 Cocrystal of Barbituric acid and 4,4'pyrazine-N,N'-dioxide
C4H4N2O3,0.5(C4H4N2O2)
Molecular Pharmaceutics (2007) 4, 3 417
a=5.258(3)Å b=6.478(3)Å c=22.118(11)Å
α=90.00° β=95.795(8)° γ=90.00°
1:1 complex of saccharin and bipyridine-N,N'-oxide
C10H8N2O2,2(C7H5NO3S)
Molecular Pharmaceutics (2007) 4, 3 417
a=6.5207(4)Å b=14.0377(9)Å c=13.1232(9)Å
α=90.00° β=104.2800(10)° γ=90.00°
2:1 cocrystal of 4-methylpyridine-N-oxide and barbital
C8H12N2O3,C5H5NO
Molecular Pharmaceutics (2007) 4, 3 417
a=7.2276(5)Å b=19.5811(12)Å c=9.9928(6)Å
α=90.00° β=98.1360(10)° γ=90.00°
Hydrate of 1:1 cocrystal of 4-hydroxy benzamide and pyrazine-4,4'-dioxide
C7H7NO2,0.5(C4H4N2O2),H2O
Molecular Pharmaceutics (2007) 4, 3 417
a=6.409(4)Å b=7.372(4)Å c=11.064(6)Å
α=96.127(14)° β=97.22(3)° γ=105.350(9)°
2:4 Cocrystal of Barbital acid and 4-methylpyridine N-oxide
C8H12N2O3,2(C6H7NO)
Molecular Pharmaceutics (2007) 4, 3 417
a=8.2106(5)Å b=23.9166(15)Å c=20.6318(13)Å
α=90.00° β=96.6700(10)° γ=90.00°
1:0.5 cocrystal of Carbamazepine and Quinoxaline-N,N'-dioxide
C15H12N2O,C8H6N2O2
Molecular Pharmaceutics (2007) 4, 3 417
a=7.284(2)Å b=10.688(4)Å c=14.132(5)Å
α=100.250(5)° β=102.463(5)° γ=109.079(5)°
1:0.5 cocrystal of Carbamazepine and pyrazine-N,N'-dioxide
C15H12N2O,0.5(C4H4N2O2)
Molecular Pharmaceutics (2007) 4, 3 417
a=10.237(4)Å b=27.247(12)Å c=5.135(2)Å
α=90.00° β=102.708(7)° γ=90.00°
Sparfloxacin-Propylparaben cocrystal
C19H22F2N4O3,C10H10O3
Chemical communications (Cambridge, England) (2016) 52, 85 12610-12613
a=7.9588(4)Å b=10.3333(5)Å c=17.8484(9)Å
α=80.749(4)° β=87.489(4)° γ=72.019(5)°